Zyprexa

It has signed deals worth $1.6 billion in December alone to license in new drugs, and is buying up KuDOS, a cancer research firm.

AstraZeneca's shares fell 4 per cent Wednesday in reaction to the news, trading at 26.87 pounds.

Posted on : Thu, 19 Jan 2006 14:35 GMT | Business News By : Paula Jenkins Related AMD gets back to profit mode, snatches market share from Intel Pearson reports strong growth in 2005 sales Aga Foodservice hopes 2005 results to toe market forecasts Eurostar focus on business travellers yielding results Tesco all set to report bumper Christmas sales In the Know...

Banking News Business News Credit Cards News Debt News General News Insurance News Investments News Loans News Mortgages News Pensions News Politics News Loans Explained...

Personal loan Secured loan Home loan bad Credit loans Unsecured loan Debt consolodation loan UK loan application Non status loan Non status mortgage Tenant loan Credit card application faqs UK credit card companies Student loan Bridging loan Car loan UK loan companies Fast loan Alternatives...

FujiPhoto focuses on digital future; snaps up ink-dye maker Avecia SkyePharma has an unsolicited suitor, engages Lehman Bros to adv...

Read more...